Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn | 1,282.00 |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn | -1,020.00 |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn | -2,093.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 396.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 856.00 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -258,655.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 944.00 |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn | -156.00 |
| 9 | Fennec Pharmaceuticals | 401.07 Mn | 359.82 Mn | 17.15 Mn | 17,296.00 |
| 10 | RedHill Biopharma | 179.86 Mn | 179.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,093.00 |
| Mar 31, 2026 | -2,472.00 |
| Dec 31, 2025 | -344.00 |
| Sep 30, 2025 | -331.00 |
| Jun 30, 2025 | -581.00 |
| Mar 31, 2025 | 1,901.00 |
| Dec 31, 2024 | 1,113.00 |
| Sep 30, 2024 | 565.00 |
| Jun 30, 2024 | 252.00 |
| Mar 31, 2024 | 753.00 |
| Dec 31, 2023 | 828.00 |
| Sep 30, 2023 | 2,202.00 |
| Jun 30, 2023 | 1,019.00 |
| Mar 31, 2023 | 741.00 |
| Dec 31, 2022 | 496.00 |
| Sep 30, 2022 | 3,620.00 |
| Jun 30, 2022 | 1,220.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -333.00 |
| Sep 30, 2021 | 318.00 |